Atrial Fibrillation and Flutter
22
3
4
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
9%
2 trials in Phase 3/4
8%
1 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (22)
Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy
Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE
Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients
Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation
Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization
Clinical Decision Support for Atrial Fibrillation and Flutter
Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
A Clinical Trial of the Use of Remote Heart Rhythm Monitoring With a Smartphone After Cardiac Surgery
Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial
Effect of Targeted Education for Atrial Fibrillation Patients
Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)
Dielectric Tissue Imaging in Cavotricuspid Isthmus Ablation
Development of a New Impedance Mapping System for Ablation of Atrial Arrhythmias in Patients
Aino ECG Ambulatory Study
HIgh Power Short Duration Radiofrequency Ablation or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation
Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead
Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study
Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis